We are live on ! Find out more
NIM

NEOS Investment Management Portfolio holdings

AUM $19.8B
1-Year Est. Return 31.12%
This Fund
S&P 500
This Quarter Est. Return
-3.62%
1 Year Est. Return
+31.12%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.27B
AUM Growth
+$1.03B
Cap. Flow
+$1.33B
Cap. Flow %
25.3%
Top 10 Hldgs %
33.76%
Holding
622
New
34
Increased
508
Reduced
35
Closed
25

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$87.7M
2
NVDA icon
NVIDIA
NVDA
+$78.5M
3
MSFT icon
Microsoft
MSFT
+$77.3M
4
AMZN icon
Amazon
AMZN
+$56M
5
META icon
Meta Platforms (Facebook)
META
+$35.6M

Top Sells

Rank Stock Value
1
PRIM icon
Primoris Services
PRIM
+$7.16M
2
FLR icon
Fluor
FLR
+$5.32M
3
FSS icon
Federal Signal
FSS
+$5.11M
4
ALLE icon
Allegion
ALLE
+$3.66M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$2.53M

Sector Composition

Rank Sector Weight
1 Technology 31.85%
2 Healthcare 10.37%
3 Communication Services 9.8%
4 Consumer Discretionary 9.65%
5 Financials 8.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALEC icon
601
Alector
ALEC
$223M
– –
-14,344
Closed -$27.1K
ALLE icon
602
Allegion
ALLE
$14.3B
– –
-28,014
Closed -$3.66M
BWA icon
603
BorgWarner
BWA
$14.1B
– –
-11,183
Closed -$356K
CLDX icon
604
Celldex Therapeutics
CLDX
$3.47B
– –
-20,261
Closed -$512K
CRSP icon
605
CRISPR Therapeutics
CRSP
$5.16B
– –
-16,231
Closed -$639K
EME icon
606
Emcor
EME
$36B
– –
-1,020
Closed -$463K
EXAS
607
DELISTED
Exact Sciences
EXAS
– –
-15,008
Closed -$843K
FLR icon
608
Fluor
FLR
$7.14B
– –
-107,800
Closed -$5.32M
FSS icon
609
Federal Signal
FSS
$7.86B
– –
-55,272
Closed -$5.11M
IEX icon
610
IDEX
IEX
$17.5B
– –
-965
Closed -$202K
KROS icon
611
Keros Therapeutics
KROS
$211M
– –
-35,663
Closed -$565K
MLYS icon
612
Mineralys Therapeutics
MLYS
$2.39B
– –
-89,529
Closed -$1.1M
PKG icon
613
Packaging Corp of America
PKG
$23B
– –
-966
Closed -$217K
PRIM icon
614
Primoris Services
PRIM
$4.44B
– –
-93,734
Closed -$7.16M
SMR icon
615
NuScale Power
SMR
$3.94B
– –
-16,560
Closed -$297K
SRPT icon
616
Sarepta Therapeutics
SRPT
$1.87B
– –
-1,943
Closed -$236K
SRRK icon
617
Scholar Rock
SRRK
$6.37B
– –
-4,836
Closed -$209K
SWTX
618
DELISTED
SpringWorks Therapeutics
SWTX
– –
-30,811
Closed -$1.11M
TERN
619
DELISTED
Terns Pharmaceuticals
TERN
– –
-79,696
Closed -$442K
ZBRA icon
620
Zebra Technologies
ZBRA
$18.1B
– –
-707
Closed -$273K
ITCI
621
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-3,388
Closed -$283K
NARI
622
DELISTED
Inari Medical, Inc. Common Stock
NARI
– –
-14,790
Closed -$755K
21 22 23 24
25

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $19.8B AUM 19.53% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return

NEOS Investment Management's Q1 2025 Portfolio in Review

As of Q1 2025, NEOS Investment Management held 622 positions worth $5.27B, up 24% from $4.25B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

NEOS Investment Management deployed $1.33B of net new capital in Q1 2025, opening 34 new positions and adding to 508 existing holdings. Its largest new stake was OGE Energy: 73,034 shares worth $3.36M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Alnylam Pharmaceuticals, an estimated $2.53M trimmed.

  • NEOS Investment Management's largest Q1 2025 buy was OGE Energy: 73,034 shares worth $3.36M.
  • NEOS Investment Management added most to Apple in Q1 2025, an estimated $87.7M increase.
  • NEOS Investment Management's biggest Q1 2025 reduction was Alnylam Pharmaceuticals, cutting an estimated $2.53M.
  • NEOS Investment Management fully exited Primoris Services in Q1 2025, selling an estimated $7.16M.
  • NEOS Investment Management's ten largest holdings make up 34% of its $5.27B portfolio in Q1 2025.
  • NEOS Investment Management opened 34 new positions and closed 25 in Q1 2025.
  • NEOS Investment Management's portfolio value rose 24% quarter-over-quarter to $5.27B.

Based on NEOS Investment Management's 13F filing for Q1 2025, filed 15 May 2025.